Cargando…
Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromes
OBJECTIVE: Dual antiplatelet therapy can reduce coronary thrombosis and improve the prognosis in patients with acute coronary syndrome (ACS). However, there was limited prognostic information about fibrinolytic dysregulation in patients with ACS. This study is aimed to evaluated the prevalence and i...
Autores principales: | Wan, Huaibin, Fan, Xin, Wu, Zhihao, Lie, Zhenbang, Li, Daqiang, Su, Shaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141118/ https://www.ncbi.nlm.nih.gov/pubmed/34022898 http://dx.doi.org/10.1186/s12959-021-00288-5 |
Ejemplares similares
-
Validation of plasma D-dimer in Chinese patients with acute non-ST segment elevation myocardial infarction
por: Fan, Xin, et al.
Publicado: (2022) -
Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010) -
Gene expression of fibrinolytic markers in coronary thrombi
por: Nordeng, Jostein, et al.
Publicado: (2022) -
Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia
por: Wu, Wei, et al.
Publicado: (2016) -
Changes in the Fibrinolytic System of Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2
por: Abudouleh, Esra’a, et al.
Publicado: (2023)